|
Stallergenes - Company Profile Snapshot
| Company Profile: |
Stallergenes |
| Ticker: |
GENP |
| Exchanges: |
PAR |
| 2008 Sales: |
170,880,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
FRANCE |
| Employees: |
782 |
Business Description
Stallergenes. The Group's principal activity is to develop, produce and distribute immunotherapy solutions to treat allergies. The Group offers allergen extracts used to correct the immune imbalance. The Group supplies therapeutic products for diagnostic purpose as well as treatments. Under diagnostic purpose, the Group offers prick tests and vitro tests which help medical professionals to confirm the diagnosis. Under treatments, the Group offers subcutaneous injections, and sublingual drops. The Group operates mainly in France, Spain, Portugal, Italy, Greece and Switzerland.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
